Today, treatment decisions for patients with mantle cell lymphoma are heavily based on age alone, although the disease can range from slow-growing (indolent) to very aggressive. In a new journal article, Ingrid Glimelius and co-authors suggest that it is time to let the disease's biology also guide treatment—and provide more effective interventions earlier for those at the highest risk of…
Of 11 clinics contacted by CNA, three said they had run out of the Southern Hemisphere vaccine, while another said it had little stock left amid a rise in demand for flu jabs.
Of 11 clinics contacted by CNA, three said they had run out of the Southern Hemisphere vaccine, while another said it had little stock left amid a rise in demand for flu jabs.
Mikel Arteta has said Arsenal defender William Saliba is making 'positive' progression in his return from a back issue but has not placed a timeline on his return.Saliba has been sidelined since…
Ionis Pharmaceuticals got FDA approval of its rare neurodegenerative disease treatment zilganersen, paving the way for the company’s first wholly owned neurology product.
A Shanghai and Boston biotech led by a veteran transpacific drug developer has secured more than $80 million to advance three clinical-stage brain-health drugs.
